NFKB1 and Parkinson disease: Thus, to appraise their possible application as disease markers, Ghafouri-Fard et al. identified circulating lncRNAs involved in the modulation of NF-kB signaling in the circulation of patients with PD versus healthy individuals, including CEBPA, ATG5, PACER, DILC, NKILA, ADINR, DICER1-AS1, HNF1A-AS1, CHAST, and H19.